|
|
positive regulation of mrna 3 end processing
|
GO:0031442 |
12 |
1.000
|
Human |
|
|
regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900151 |
8 |
0.998
|
Human |
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
8 |
0.991
|
Human |
|
|
positive regulation of mrna catabolic process
|
GO:0061014 |
10 |
0.983
|
Human |
|
|
positive regulation of mrna processing
|
GO:0050685 |
17 |
0.976
|
Human |
|
|
nuclear transcribed mrna catabolic process exonucleolytic
|
GO:0000291 |
7 |
0.945
|
|
|
|
regulation of mrna 3 end processing
|
GO:0031440 |
12 |
0.938
|
Human |
|
|
regulation of mrna catabolic process
|
GO:0061013 |
13 |
0.935
|
Human |
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
2 |
0.930
|
|
|
|
positive regulation of mrna metabolic process
|
GO:1903313 |
19 |
0.927
|
Human |
|
|
rna phosphodiester bond hydrolysis exonucleolytic
|
GO:0090503 |
14 |
0.889
|
|
|
|
mrna catabolic process
|
GO:0006402 |
56 |
0.879
|
Human |
|
|
mrna 3 end processing
|
GO:0031124 |
24 |
0.848
|
Human |
|
|
rna catabolic process
|
GO:0006401 |
71 |
0.840
|
Human |
|
|
positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900153 |
8 |
0.814
|
Human |
|
|
nuclear transcribed mrna catabolic process
|
GO:0000956 |
48 |
0.732
|
Human |
|
|
nuclear transcribed mrna poly a tail shortening
|
GO:0000289 |
8 |
0.702
|
Human |
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
14 |
0.681
|
Human |
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
8 |
0.639
|
Human |
|
|
rna 3 end processing
|
GO:0031123 |
35 |
0.631
|
Human |
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.631
|
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
26 |
0.599
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.538
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.506
|
Human |
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.487
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.486
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.436
|
Human |
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.426
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.414
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.404
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.395
|
Human |
|
|
post embryonic development
|
GO:0009791 |
2 |
0.392
|
|
|
|
rna phosphodiester bond hydrolysis
|
GO:0090501 |
35 |
0.326
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.325
|
Human |
|
|
translation
|
GO:0006412 |
132 |
0.321
|
Human |
|
|
cell development
|
GO:0048468 |
328 |
0.316
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.316
|
Human |
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.297
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.297
|
Human |
|
|
exonucleolytic nuclear transcribed mrna catabolic process involved in deadenylation dependent decay
|
GO:0043928 |
6 |
0.292
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.278
|
Human |
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.253
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.221
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.220
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.219
|
Human |
|
|
positive regulation of fibroblast apoptotic process
|
GO:2000271 |
6 |
0.217
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.213
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.210
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
53 |
0.205
|
Human |
|
|
mrna processing
|
GO:0006397 |
133 |
0.204
|
Human |
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.201
|
Human |
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.200
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
48 |
0.199
|
Human |
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.182
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.181
|
|
|
|
cytoplasmic mrna processing body assembly
|
GO:0033962 |
10 |
0.179
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
57 |
0.170
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.170
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.166
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.162
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.153
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.153
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.146
|
Human |
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.140
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.139
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.134
|
Human |
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.127
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.125
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.125
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.124
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.119
|
Human |
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.114
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.113
|
|
|
|
regulation of translation
|
GO:0006417 |
89 |
0.112
|
Human |
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.110
|
|
|
|
regulation of stem cell maintenance
|
GO:2000036 |
4 |
0.110
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
1 |
0.109
|
|
|
|
system process
|
GO:0003008 |
349 |
0.107
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.104
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.104
|
Human |
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.103
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.102
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.100
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.099
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.098
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.098
|
Rat |
|
|
organelle assembly
|
GO:0070925 |
176 |
0.097
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.097
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.095
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.094
|
|
|
|
regulation of cytoplasmic mrna processing body assembly
|
GO:0010603 |
5 |
0.093
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.088
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.086
|
|
|
|
growth
|
GO:0040007 |
202 |
0.083
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.083
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.082
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.082
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.076
|
|
|
|
fibroblast apoptotic process
|
GO:0044346 |
8 |
0.076
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.075
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.074
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.073
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.072
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.071
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.071
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.070
|
Human |
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.069
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.069
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.068
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.068
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.068
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.065
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.062
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.062
|
|
|
|
positive regulation of cytoplasmic mrna processing body assembly
|
GO:0010606 |
4 |
0.061
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.061
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.059
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.059
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.058
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.056
|
|
|
|
ribonucleoprotein complex assembly
|
GO:0022618 |
78 |
0.056
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.055
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.054
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.054
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.054
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.054
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.053
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.052
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.049
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.049
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.049
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.048
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.048
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.047
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.047
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.047
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.047
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.047
|
|
|
|
gene silencing
|
GO:0016458 |
49 |
0.047
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.047
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.046
|
|
|
|
regulation of muscle cell differentiation
|
GO:0051147 |
31 |
0.045
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.045
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.045
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.045
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.045
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.044
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.044
|
Rat |
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.043
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.043
|
|
|
|
negative regulation of translation
|
GO:0017148 |
37 |
0.043
|
Human |
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.043
|
Human |
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.043
|
|
|
|
positive regulation of myoblast differentiation
|
GO:0045663 |
6 |
0.043
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.043
|
Rat |
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.042
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.042
|
Rat |
|
|
protein processing
|
GO:0016485 |
226 |
0.042
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
50 |
0.042
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
81 |
0.041
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.041
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.041
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.040
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.040
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.040
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.040
|
|
|
|
nuclear transcribed mrna catabolic process nonsense mediated decay
|
GO:0000184 |
23 |
0.040
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.039
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.039
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.039
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.039
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.039
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.038
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.038
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.038
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.038
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.037
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.037
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
26 |
0.037
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.037
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.037
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.036
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.036
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.036
|
Human |
|
|
nuclear transcribed mrna catabolic process no go decay
|
GO:0070966 |
2 |
0.035
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.035
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.035
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.035
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.035
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.035
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.034
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.034
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.034
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.034
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.034
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.033
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.033
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.033
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.032
|
|
|
|
regulation of endothelial cell differentiation
|
GO:0045601 |
4 |
0.032
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.032
|
Rat |
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.032
|
Rat |
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.032
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.032
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.031
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.031
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.031
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.030
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.030
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.030
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.029
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
67 |
0.029
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.029
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.029
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.028
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.028
|
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
7 |
0.028
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.027
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.027
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.027
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.027
|
Human |
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.027
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.027
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
35 |
0.027
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.027
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.026
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.026
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.026
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.026
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.026
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.026
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.026
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.026
|
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
9 |
0.026
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.026
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.026
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.026
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.025
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.025
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.025
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.025
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.025
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.025
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.025
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.025
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.025
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.025
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.025
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.024
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.024
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.024
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.024
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.024
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.024
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.024
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.024
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.024
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.024
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.023
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.023
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.023
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.023
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.023
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.023
|
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.023
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.023
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.023
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.023
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.022
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.022
|
|
|
|
regulation of striated muscle tissue development
|
GO:0016202 |
26 |
0.022
|
|
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
1 |
0.022
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.022
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.022
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.022
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.022
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.022
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.021
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.021
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.021
|
Rat |
|
|
circulatory system process
|
GO:0003013 |
113 |
0.021
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.021
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.021
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.021
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.021
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.021
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.021
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.021
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.021
|
Rat |
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.021
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.021
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.021
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.021
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
2 |
0.021
|
|
|
|
t cell differentiation
|
GO:0030217 |
29 |
0.021
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.021
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.020
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.020
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.020
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.020
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.020
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.020
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.020
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
18 |
0.020
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.020
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.020
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.020
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.020
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.020
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.019
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.019
|
|
|
|
regulation of neuron death
|
GO:1901214 |
56 |
0.019
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.019
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.019
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.019
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.019
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.019
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.019
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.019
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.019
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.019
|
|
|
|
regulation of fibroblast apoptotic process
|
GO:2000269 |
8 |
0.019
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
48 |
0.019
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.019
|
|
|
|
cranial nerve formation
|
GO:0021603 |
1 |
0.019
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.019
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.019
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.019
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.019
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
54 |
0.018
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
1 |
0.018
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.018
|
|
|
|
mitochondrial transport
|
GO:0006839 |
60 |
0.018
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.018
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
15 |
0.018
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
59 |
0.018
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.018
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.018
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.018
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.018
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.018
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.018
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.018
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.018
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.018
|
Rat |
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.018
|
Human |
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.018
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.018
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.017
|
|
|
|
negative regulation of retinoic acid receptor signaling pathway
|
GO:0048387 |
4 |
0.017
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
23 |
0.017
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.017
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
74 |
0.017
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.017
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.017
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.017
|
|
|
|
deadenylation dependent decapping of nuclear transcribed mrna
|
GO:0000290 |
1 |
0.017
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.017
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.017
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.017
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.017
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.017
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.016
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
3 |
0.016
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
34 |
0.016
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
18 |
0.016
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.016
|
|
|
|
protein methylation
|
GO:0006479 |
74 |
0.016
|
Mouse |
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.016
|
|
|
|
striated muscle contraction
|
GO:0006941 |
52 |
0.016
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.016
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.016
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.016
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.016
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.016
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.016
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.016
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.016
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.016
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
51 |
0.016
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.016
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.016
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.016
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.016
|
|
|
|
positive regulation of organelle assembly
|
GO:1902117 |
17 |
0.016
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.016
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.015
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.015
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.015
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
3 |
0.015
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.015
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
3 |
0.015
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.015
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.015
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.015
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.015
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.015
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.015
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.015
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.015
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.015
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
4 |
0.015
|
|
|
|
regulation of ligand dependent nuclear receptor transcription coactivator activity
|
GO:2000325 |
3 |
0.015
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.015
|
|
|
|
negative regulation of erythrocyte differentiation
|
GO:0045647 |
3 |
0.014
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
24 |
0.014
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.014
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.014
|
Mouse |
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.014
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.014
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.014
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.014
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
55 |
0.014
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.014
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.014
|
|
|
|
positive regulation of binding
|
GO:0051099 |
45 |
0.014
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.014
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.014
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.014
|
|
|
|
stem cell maintenance
|
GO:0019827 |
19 |
0.014
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.014
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.014
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.014
|
|
|
|
heart process
|
GO:0003015 |
62 |
0.014
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.014
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.014
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
40 |
0.014
|
|
|
|
regulation of transcription elongation from rna polymerase ii promoter
|
GO:0034243 |
13 |
0.013
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.013
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.013
|
Mouse |
|
|
regulation of myoblast differentiation
|
GO:0045661 |
12 |
0.013
|
|
|
|
regulation of growth rate
|
GO:0040009 |
1 |
0.013
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.013
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
38 |
0.013
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
43 |
0.013
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.013
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.013
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.013
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.013
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
35 |
0.013
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
4 |
0.013
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.013
|
|
|
|
multicellular organism reproduction
|
GO:0032504 |
42 |
0.013
|
Rat |
|
|
muscle contraction
|
GO:0006936 |
73 |
0.013
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.013
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
75 |
0.013
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
32 |
0.013
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.013
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.013
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.013
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.013
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.013
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.013
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.013
|
|
|
|
mrna destabilization
|
GO:0061157 |
1 |
0.012
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.012
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.012
|
|
|
|
regulation of dna replication
|
GO:0006275 |
68 |
0.012
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.012
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.012
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.012
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.012
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.012
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.012
|
|
|
|
b cell activation
|
GO:0042113 |
33 |
0.012
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.012
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.012
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.012
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
4 |
0.012
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
79 |
0.012
|
|
|
|
positive regulation of mononuclear cell proliferation
|
GO:0032946 |
47 |
0.012
|
|
|
|
nucleus localization
|
GO:0051647 |
1 |
0.012
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
4 |
0.012
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.012
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.012
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
2 |
0.012
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
59 |
0.012
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.012
|
|
|
|
camp metabolic process
|
GO:0046058 |
61 |
0.012
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.012
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
38 |
0.012
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.012
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
2 |
0.012
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.012
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.012
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.012
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.012
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.012
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.012
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.012
|
Human |
